title: Long-term survival after brain metastases in breast cancer.
abstract: OBJECTIVE
  Long-term survival after whole brain irradiation for cerebral metastases is rare. In order to identify a possible subgroup of patients with a prolonged survival time, a retrospective analysis was carried out.
  
  
  METHODS
  From 1977 to 1991, 197 patients with singular (51%) or multiple (49%) brain metastases were treated with whole brain irradiation (30 to 36 Gy, 2 to 3 Gy daily fractions, an additional boost of 8 to 20 Gy in 8%) or resection of a singular metastasis and postoperative irradiation (36 patients, 30 to 36 Gy, 2 to 3 Gy fractions whole brain irradiation, boost of 8 to 20 Gy in 31%).
  
  
  RESULTS
  Fifty-seven patients (24%) had metastases of breast cancer. In this group, 3 of 8 patients with combined treatment of a singular metastasis survived more than 5 years from the onset of brain irradiation, compared to 1 of 8 patients with non-small-cell lung cancer and none of 14 patients with unknown primaries. In the group which was treated with irradiation only, breast cancer patients with an interval of more than 5 years between primary and brain metastasis had the best prognosis with 4 of 12 patients surviving more than 3 years, but less than 5 years.
  
  
  CONCLUSIONS
  These results demonstrate that long-term survival is not only possible in the known cases of solitary brain metastasis in non-small-cell lung cancer but also in breast cancer, combined treatment provided.
authors.affiliation: Department of Radiotherapy, University of Cologne.
authors.forename: M
authors.initials: M
authors.lastname: Kocher
authors.forename: R P
authors.initials: RP
authors.lastname: Müller
authors.forename: S
authors.initials: S
authors.lastname: Staar
authors.forename: D
authors.initials: D
authors.lastname: Degroot
mesh_terms: D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000401:mortality* / Q000556:secondary* / Q000628:therapy; D001943:Breast Neoplasms / Q000401:mortality*; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000556:secondary; D018288:Carcinoma, Small Cell / Q000401:mortality / Q000556:secondary; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care; D011879:Radiotherapy Dosage; D016019:Survival Analysis; D013997:Time Factors